Linear growth and pubertal development in treated congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
21 years experience with management of seventeen cases of congenital adrenal hyperplasia due to 21-hydroxylase deficiency has been analysed with respect to growth, bone maturation and related events at puberty: age at menarche and the occurrence of menstrual irregularities, this study showed that growth retardation is still a problem; that irregular treatment and prolonged exposure to adrenal androgens or oestrogens, may lead to disturbance in hypothalamo-pituitary-gonadal function and may be the cause fo delayed menarche, or menstrual irregularities in the case of the female. In males the start of puberty and its completion was within the normal range.
D015068:17-Ketosteroids / Q000652:urine; D000308:Adrenocortical Hyperfunction / Q000503:physiopathology*; D001827:Body Height; D001846:Bone Development; D002648:Child; D002675:Child, Preschool; D002996:Clomiphene / Q000494:pharmacology; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood; D007987:Gonadotropin-Releasing Hormone / Q000494:pharmacology; D006128:Growth; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007986:Luteinizing Hormone / Q000097:blood; D008297:Male; D008598:Menstruation; D006899:Mixed Function Oxygenases / Q000172:deficiency*; D011627:Puberty; D013739:Testosterone / Q000097:blood
D015068:17-Ketosteroids; D002996:Clomiphene; D007987:Gonadotropin-Releasing Hormone; D013739:Testosterone; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D006899:Mixed Function Oxygenases